What sites for SBRT are thought to be more immunogenic for antigen presentation when combined with immunotherapy?
If given options of liver, lung, spine, brain, axilla, or other lymph nodes which sites do you pick?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · University of Colorado School of Medicine
Answered on
I am aware of only one prospective trial structured to approach this question to some extent. It was from Jim Welsh's team at MDAH and was presented at ASTRO this year.
http://www.redjournal.org/article/S0360-3016(17)33877-4/abstract
There was a hint that sequential ipilimumab followed by RT to lung l...
Join for free or sign in to see the full answer